pillbase.ru

Vueway

Active substance: gadopiclenol

INJECTION · GADOPICLENOL 485.1 mg/mL

United StatesActive

Marketing holder: BRACCO DIAGNOSTICS INC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 2
  • Elucirem
    Gadopiclenol
    EMEA/H/C/005626
    Guerbet
  • Vueway
    Gadopiclenol
    EMEA/H/C/006172
    Bracco Imaging S.p.A.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-8fb3-7651-b80f-060c325548b6,01a1208c-9f75-7ece-8e4e-6ffc8d65131c,01a1208c-9f78-76a7-ba93-7617b0205948,01a1208e-b641-7378-8bc8-d50e1211cc44,01a12090-4539-7a4b-9749-cbcec0aa0c44;count=14 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0270-7015
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 0270-7015 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0270-7015 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0270-7015 · Verified 2026-10-09 · open in source